Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brett A Vaughn

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Chemistry (Weinheim an Der Bergstrasse, Germany)|November 20, 2019
Establishing Radiolanthanum Chemistry for Targeted Nuclear Medicine ApplicationsEduardo Aluicio-Sarduy, Nikki A Thiele, Kirsten E Martin, et al.
Bioconjugate Chemistry|December 7, 2020
Homologous Structural, Chemical, and Biological Behavior of Sc and Lu Complexes of the Picaga Bifunctional Chelator: Toward Development of Matched Theranostic Pairs for Radiopharmaceutical ApplicationsBrett A Vaughn, Angus J Koller, Zhihengyu Chen, et al.
Theranostics|May 7, 2026
Pretargeted <sup>177</sup>Lu/<sup>225</sup>Ac combination therapy of colorectal cancerSara S Rinne, Niloufar Salehi, Brett A Vaughn, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 5, 2025
<sup>225</sup>Ac α-Pretargeted Radioimmunotherapy of Human Epidermal Growth Factor Receptor 2-Expressing Breast CancerSara S Rinne, Daniela Burnes Vargas, Shin Seo, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 12, 2026
Preclinical <sup>203/212</sup>Pb-DOTA-Based Pretargeted Radioimmunotherapy in Nude Mice Bearing Established Human Colorectal Cancer XenograftsBrett A Vaughn, Darren R Veach, Daniela Burnes Vargas, et al.
Theranostics|August 4, 2025
Comparison of targeting two antigens (GPA33 versus HER2) for <sup>225</sup>Ac-pretargeted alpha-radioimmunotherapy of colorectal cancerSara S Rinne, Daniela Burnes Vargas, Brett A Vaughn, et al.
Molecular Pharmaceutics|May 19, 2026
Establishment of <sup>68</sup>Ga-DOTA-Based Pretargeted RadioimmunodiagnosisDarren R Veach, Daniela Burnes Vargas, Baharul Islam, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 21, 2024
Theranostic GPA33-Pretargeted Radioimmunotherapy of Human Colorectal Carcinoma with a Bivalent <sup>177</sup>Lu-Labeled RadiohaptenBrett A Vaughn, Sang-Gyu Lee, Daniela Burnes Vargas, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 22, 2023
Efficacy of HER2-Targeted Intraperitoneal <sup>225</sup>Ac α-Pretargeted Radioimmunotherapy for Small-Volume Ovarian Peritoneal CarcinomatosisSebastian K Chung, Daniela Burnes Vargas, Christopher S Chandler, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Chemistry (Weinheim an Der Bergstrasse, Germany)|November 20, 2019
Establishing Radiolanthanum Chemistry for Targeted Nuclear Medicine ApplicationsEduardo Aluicio-Sarduy, Nikki A Thiele, Kirsten E Martin, et al.
Bioconjugate Chemistry|December 7, 2020
Homologous Structural, Chemical, and Biological Behavior of Sc and Lu Complexes of the Picaga Bifunctional Chelator: Toward Development of Matched Theranostic Pairs for Radiopharmaceutical ApplicationsBrett A Vaughn, Angus J Koller, Zhihengyu Chen, et al.
Theranostics|May 7, 2026
Pretargeted <sup>177</sup>Lu/<sup>225</sup>Ac combination therapy of colorectal cancerSara S Rinne, Niloufar Salehi, Brett A Vaughn, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 5, 2025
<sup>225</sup>Ac α-Pretargeted Radioimmunotherapy of Human Epidermal Growth Factor Receptor 2-Expressing Breast CancerSara S Rinne, Daniela Burnes Vargas, Shin Seo, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 12, 2026
Preclinical <sup>203/212</sup>Pb-DOTA-Based Pretargeted Radioimmunotherapy in Nude Mice Bearing Established Human Colorectal Cancer XenograftsBrett A Vaughn, Darren R Veach, Daniela Burnes Vargas, et al.
Theranostics|August 4, 2025
Comparison of targeting two antigens (GPA33 versus HER2) for <sup>225</sup>Ac-pretargeted alpha-radioimmunotherapy of colorectal cancerSara S Rinne, Daniela Burnes Vargas, Brett A Vaughn, et al.
Molecular Pharmaceutics|May 19, 2026
Establishment of <sup>68</sup>Ga-DOTA-Based Pretargeted RadioimmunodiagnosisDarren R Veach, Daniela Burnes Vargas, Baharul Islam, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 21, 2024
Theranostic GPA33-Pretargeted Radioimmunotherapy of Human Colorectal Carcinoma with a Bivalent <sup>177</sup>Lu-Labeled RadiohaptenBrett A Vaughn, Sang-Gyu Lee, Daniela Burnes Vargas, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 22, 2023
Efficacy of HER2-Targeted Intraperitoneal <sup>225</sup>Ac α-Pretargeted Radioimmunotherapy for Small-Volume Ovarian Peritoneal CarcinomatosisSebastian K Chung, Daniela Burnes Vargas, Christopher S Chandler, et al.
Pageof 2